Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases

BACKGROUND: This multi-centre phase II clinical trial is the first prospective evaluation of radioembolisation of patients with colorectal liver metastases (mCRC) who failed previous oxaliplatin- and irinotecan-based systemic chemotherapy regimens. METHODS: Eligible patients had adequate hepatic, ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Cosimelli, M, Golfieri, R, Cagol, P P, Carpanese, L, Sciuto, R, Maini, C L, Mancini, R, Sperduti, I, Pizzi, G, Diodoro, M G, Perrone, M, Giampalma, E, Angelelli, B, Fiore, F, Lastoria, S, Bacchetti, S, Gasperini, D, Geatti, O, Izzo, F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920024/
https://www.ncbi.nlm.nih.gov/pubmed/20628388
http://dx.doi.org/10.1038/sj.bjc.6605770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920024/
https://www.ncbi.nlm.nih.gov/pubmed/20628388
http://dx.doi.org/10.1038/sj.bjc.6605770

Ejemplares similares